Research areas

  1. Published

    Scientific Opinion on the safety of caffeine

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 5, 120 p., 4102.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  2. Published

    Scientific Opinion on the safety of lacto-N-neotetraose as a novel food ingredient pursuant to Regulation (EC) No 258/97

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 7, 32 p., 4183.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  3. Published

    Scientific Opinion on the safety of ‘heat-treated milk products fermented with Bacteroides xylanisolvens DSM 23964’ as a novel food

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 1, 18 p., 3956.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  4. Published

    Scientific Opinion on the substantiation of a health claim related to Bifidobacterium bifidum CNCM I-3426 and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 5, 9 p., 4094.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  5. Published

    Scientific Opinion on the substantiation of a health claim related to FRUIT UP® and a reduction of post-prandial blood glucose responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 5, 12 p., 4098.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  6. Published

    Scientific Opinion on the substantiation of a health claim related to SYNBIO®, a combination of Lactobacillus rhamnosus IMC 501® and Lactobacillus paracasei IMC 502®, and maintenance of normal defecation pursuant to Article 13(5) of Regulation (EC) No 1924/2006

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 5, 12 p., 4095.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  7. Published

    Scientific Opinion on the substantiation of a health claim related to Symbiosal® and lowering of blood pressure and reduced risk of hypertension pursuant to Article 14 of Regulation (EC) No 1924/2006

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 7, 13 p., 4147.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  8. Published

    Scientific Opinion on the substantiation of a health claim related to Teestar™, a fenugreek seed extract standardised by its content of galactomannan, and a reduction of post-prandial glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 9 p., 3952.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  9. Published

    Scientific Opinion on the substantiation of a health claim related to a combination of pomegranate pomace extract and greater galangal rhizome powder and an increase in the number of motile spermatozoa in semen pursuant to Article 13(5) of Regulation (EC) No 1924/2006

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 5, 16 p., 4097.

    Research output: Contribution to journalJournal articleCommissionedpeer-review

  10. Published

    Scientific Opinion on the substantiation of a health claim related to an equimolar mixture of the CLA isomers c9,t11 and t10,c12 (marketed as Clarinol® and Tonalin®) and “contributes to a reduction in body fat mass” pursuant to Article 13(5) of Regulation (EC) No 1924/2006

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), E. P. O. D. P. N. A. A. (., 2015, In: E F S A Journal. 13, 1, 11 p., 3953.

    Research output: Contribution to journalJournal articleCommissionedpeer-review